Does biology or therapy define oncology outcomes?
The debate over the relative impact on survival outcomes of therapy versus the inherent biology of an individual patient’s cancer remains one of the most controversial areas in all of cancer medicine. Even the results of well-designed and conducted phase III clinical trials cannot alter the opinion of many that observed equivalent survival outcomes between different therapeutic strategies are clinically irrelevant since “treatment in the study was not optimally applied.”
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063